Psychedelic-assisted psychotherapy (PAP) in bereavement support may have benefits for families coping with the loss of a loved one. However, gauging the potential impacts of psychedelic utilization among grieving individuals requires careful consideration when assessing quality outcomes, according to Ryan Moss, chief science officer at Filament Health Corp. The clinical-stage natural psychedelic drug development company […]